Royalty Pharma: EVP Marshall Urist sells $235,594 Class A shares

Royalty Pharma EVP, Research & Investments Marshall Urist sold 4,126 Class A ordinary shares on Oct. 5, 2026 at USD 57.1. Direct holdings fell to 0 shares. He reported 19,020 Class A ordinary shares held indirectly through an IRA.